Evidence map›Paper›PMID 27557093›Full record

ArticleEnvironmental health perspectives2017

Climate Change and Future Pollen Allergy in Europe.

Iain R Lake, Natalia R Jones, Maureen Agnew, Clare M Goodess, Filippo Giorgi, Lynda Hamaoui-Laguel, Mikhail A Semenov, Fabien Solmon, Jonathan Storkey, Robert Vautard and 1 more

Erratum issuedOpen access · diamondAbstract read
In one paragraph

Article in Environmental health perspectives, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 109 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 1 synthesis or guideline pooled it, 369 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Association of Short-Term Pollen Exposure With Lung Function in COPD Patients.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Effect of initiation treatment timing on efficacy ofThe World Allergy Organization journal · 2026
    Article
  10. Airborne Ragweed (Life (Basel, Switzerland) · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Iain R LakeSchool of Environmental Sciences, University of East Anglia, Norwich, United Kingdom.
Natalia R Jones
Maureen Agnew
Clare M Goodess
Filippo Giorgi
Lynda Hamaoui-Laguel
Mikhail A Semenov
Fabien Solmon
Jonathan Storkey
Robert Vautard
Michelle M Epstein
University of East Anglia · GBCentre National de la Recherche Scientifique · FRRothamsted Research · GBThe Abdus Salam International Centre for Theoretical Physics (ICTP) · ITMedical University of Vienna · AT

Funding

Biotechnology and Biological Sciences Research Council BBS/E/C/00004938
6 · The paper itself

Abstract

backgroundGlobally, pollen allergy is a major public health problem, but a fundamental unknown is the likely impact of climate change. To our knowledge, this is the first study to quantify the consequences of climate change upon pollen allergy in humans.

objectivesWe produced quantitative estimates of the potential impact of climate change upon pollen allergy in humans, focusing upon common ragweed (

methodsA process-based model estimated the change in ragweed's range under climate change. A second model simulated current and future ragweed pollen levels. These findings were translated into health burdens using a dose-response curve generated from a systematic review and from current and future population data. Models considered two different suites of regional climate/pollen models, two greenhouse gas emissions scenarios [Representative Concentration Pathways (RCPs) 4.5 and 8.5], and three different plant invasion scenarios.

resultsOur primary estimates indicated that sensitization to ragweed will more than double in Europe, from 33 to 77 million people, by 2041-2060. According to our projections, sensitization will increase in countries with an existing ragweed problem (e.g., Hungary, the Balkans), but the greatest proportional increases will occur where sensitization is uncommon (e.g., Germany, Poland, France). Higher pollen concentrations and a longer pollen season may also increase the severity of symptoms. Our model projections were driven predominantly by changes in climate (66%) but were also influenced by current trends in the spread of this invasive plant species. Assumptions about the rate at which ragweed spreads throughout Europe had a large influence upon the results.

conclusionsOur quantitative estimates indicate that ragweed pollen allergy will become a common health problem across Europe, expanding into areas where it is currently uncommon. Control of ragweed spread may be an important adaptation strategy in response to climate change. Citation: Lake IR, Jones NR, Agnew M, Goodess CM, Giorgi F, Hamaoui-Laguel L, Semenov MA, Solomon F, Storkey J, Vautard R, Epstein MM. 2017. Climate change and future pollen allergy in Europe. Environ Health Perspect 125:385-391; http://dx.doi.org/10.1289/EHP173.

Indexed as

PollenAllergensClimate ChangeEnvironmental ExposureEuropeHypersensitivityRhinitis, Allergic, SeasonalAllergens

Identifiers

PMID27557093
PMCPMC5332176
OpenAlexW2510718844

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.